Incidence and severity of retinopathy of prematurity in Turkey

Basit Öğe Kaydı
dc.authorscopusid15831078500
dc.authorscopusid7004398214
dc.authorscopusid35274681900
dc.authorscopusid32367772800
dc.authorscopusid6701864554
dc.authorscopusid12243995100
dc.authorscopusid55891323900
dc.contributor.authorBas A.Y.
dc.contributor.authorKoc E.
dc.contributor.authorDilmen U.
dc.contributor.authorOguz S.S.
dc.contributor.authorOvali F.
dc.contributor.authorDemirel N.
dc.contributor.authorZenciroglu A.
dc.date.accessioned2024-06-12T10:25:33Z
dc.date.available2024-06-12T10:25:33Z
dc.date.issued2015
dc.description.abstractBackground: The purpose of this study was to estimate the current incidence of retinopathy of prematurity (ROP) and the need for treatment in preterm infants in Turkey. Methods: The study included preterm infants who had been screened for ROP between 2011 and 2013 in 49 neonatal intensive care units. Infants with birth weight (BW) ?1500 g or ?32 weeks' gestational age and those with BW >1500 g or >32 weeks' GA with an unstable clinical course were included. The incidence of any ROP or severe ROP and treatment modalities were determined. Results: The study population included 15 745 preterm infants: 11 803 (75%) with GA ?32 weeks, and 3942 (25%) with GA >32 weeks. Overall, 30% were found to have any stage of ROP, and 5% had severe ROP. Severe ROP was diagnosed in 8.2% of infants with BW ?1500 g and 0.6% of infants with BW >1500 g. Of all infants diagnosed with ROP, 16.5% needed laser photocoagulation, and 20 patients born at >32 weeks' GA required this treatment modality. Vitroretinal surgery was performed in 28 infants with severe ROP: 23 with GA ?28 weeks and 5 with GA 29-32 weeks. Conclusions: The findings of our study have the important implication that more mature babies are at risk of severe ROP requiring treatment. An effective programme for detecting and treating ROP should be established in Turkey.en_US
dc.identifier.doi10.1136/bjophthalmol-2014-306286
dc.identifier.endpage1314en_US
dc.identifier.issn0007-1161
dc.identifier.issue10en_US
dc.identifier.pmid25868788en_US
dc.identifier.scopus2-s2.0-84942342233en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1311en_US
dc.identifier.urihttps://doi.org/10.1136/bjophthalmol-2014-306286
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16376
dc.identifier.volume99en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.ispartofBritish Journal of Ophthalmologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBirth Weight; Controlled Study; Disease Severity; Gestational Age; Human; Incidence; Infant; Low Level Laser Therapy; Major Clinical Study; Newborn Intensive Care; Prematurity; Prevalence; Priority Journal; Retrolental Fibroplasia; Retrospective Study; Review; Turkey (Republic); Clinical Trial; Female; Incidence; Infant, Premature, Diseases; Male; Multicenter Study; Newborn; Newborn Screening; Prematurity; Procedures; Retinopathy Of Prematurity; Risk Factor; Severity Of Illness Index; Turkey; Female; Gestational Age; Humans; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Neonatal Screening; Retinopathy Of Prematurity; Retrospective Studies; Risk Factors; Severity Of Illness Index; Turkeyen_US
dc.titleIncidence and severity of retinopathy of prematurity in Turkeyen_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu